SCHEMBL19783341

SCHEMBL19783341

OCc1cccc2nc(Br)sc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MAOB P27338 1/20 0.32
RXFP1 Q9HBX9 2/20 0.32
PDE10A Q9Y233 1/20 0.32
APOBEC3G Q9HC16 1/20 0.31
MAPT P10636 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
AKR1B1 P15121 1/20 0.31
KDM4E B2RXH2 1/20 0.31
TP53 P04637 1/20 0.31
PPARG P37231 1/20 0.31
NCOA2 Q15596 1/20 0.31
NCOA1 Q15788 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189662 1.00 KMT2A (0.36) KMT2AMEN1NPC1RAB9AMAOB
SCHEMBL543524 0.80 HSD17B10 (0.44) KMT2AMEN1NPC1RAB9APDE10A
SCHEMBL8975809 0.80 PDE10A (0.31) KMT2AMEN1NPC1RAB9APDE10A
SCHEMBL5124741 0.76 APP (0.46) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL5124979 0.72 RAB9A (0.43) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL31389941 0.71 PSMB8 (0.37) KMT2AMEN1NPC1RAB9APDE10A
SCHEMBL18791158 0.71 PSMB8 (0.58) KMT2AMEN1PDE10AMAPTSMN1; SMN2
SCHEMBL10187249 0.70 RAB9A (0.32) NPC1RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL22342060 0.70 PAX8 (0.41) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL5118299 0.69 ALDH1A1 (0.47) KMT2AMEN1NPC1RAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 KMT2A 2420/4885MEN1 1767/4885NPC1 2639/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 KMT2A 2390/4885MEN1 1492/4885NPC1 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.